Cargando…
Use of Tachycardia in Patients With Submassive Pulmonary Emboli to Risk Stratify for Early Initiation of Thrombolytic Therapy: A Case Series Comparing Early Versus Late Thrombolytic Initiation
Pulmonary embolism (PE) represents a prevalent cause of morbidity and mortality in the United States, with approximately 600 000 cases diagnosed annually. The mortality rate for untreated PE is as high as 30%. Right ventricular (RV) dysfunction is a sign of possible adverse outcomes with right-sided...
Autores principales: | Cheta, Jordana, Long, Ashleigh, Marik, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734466/ https://www.ncbi.nlm.nih.gov/pubmed/29276710 http://dx.doi.org/10.1177/2324709617744232 |
Ejemplares similares
-
Thrombolytic therapy in submassive pulmonary embolism
por: Özlek, Eda, et al.
Publicado: (2017) -
Thrombolytic and anticoagulant therapy for acute submassive pulmonary embolism
por: FEI, JIANWEN, et al.
Publicado: (2014) -
The Role of Thrombolytic Therapy for Patients with a Submassive Pulmonary Embolism
por: Murphy, Elizabeth, et al.
Publicado: (2018) -
Efficacy and Safety of Thrombolytic Therapy in Acute Submassive Pulmonary Embolism: Follow-Up Study
por: Sinha, Santosh Kumar, et al.
Publicado: (2017) -
The Difficult Clinical Decision of Thrombolytic Therapy for Submassive Pulmonary Embolism in a Community Hospital
por: Zhang, Qian, et al.
Publicado: (2020)